Literature DB >> 33011197

Involvement of endoplasmic reticulum stress in amyloid β (1-42)-induced Alzheimer's like neuropathological process in rat brain.

Poonam Goswami1, Mohd Amir Afjal1, Juheb Akhter1, Anuradha Mangla1, Jasim Khan2, Suhel Parvez3, Sheikh Raisuddin4.   

Abstract

Amyloid-β (Aβ) accumulation in the brain is a pathological hallmark of Alzheimer's disease (AD). Endoplasmic reticulum (ER) stress has been implicated in aetiology of neurodegenerative disorders. We studied the involvement of ER stress in Aβ-induced neuronal degeneration in rat brain to correlate it with cellular and molecular modifications in Aβ-induced Alzheimer's like neuropathological process. Aβ (1-42) (5 μg) was administered by bilateral intracerebroventricular (icv) injection in the brain of adult male Wistar rats. Acetylcholinesterase (AChE) activity and histological alterations were observed in different brain regions. ER stress-associated proteins- glucose regulated protein-78 (GRP78), eukaryotic translation initiation factor-2α (eIF2α) and growth arrest and DNA damage-inducible protein-153 (GADD153), neuronal marker- microtubule associated protein-2 (MAP-2) and microglial protein- ionized calcium binding adaptor molecule-1 (Iba-1) were measured by western blot. Reduced glutathione (GSH), nitrite level and levels of caspase-12 and caspase-3 were also measured. ER stress inhibitor, salubrinal (1 mg/kg, intraperitoneally, ip) was used to assess the specific role of ER stress. Aβ (1-42)-induced increase in AChE activity, GRP78 and GADD protein levels, dephosphorylation of eIF2-α and caspase-12 and caspase-3 levels and decrease in GSH and MAP-2 levels were attenuated by salubrinal. Increase in Iba-1 protein and nitrite levels after Aβ (1-42) administration were partially attenuated by salubrinal. Aβ (1-42)-induced histological alterations were correlated with findings of ER stress. Results of present study implicate ER stress as a potential molecular mechanism in Aβ-induced Alzheimer's like neuropathology which could serve as surrogate biomarker for study of AD progression and efficacy of therapeutic interventions for AD management.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Apoptosis; Glial activation; Oxidative stress; Salubrinal; Unfolded protein response

Year:  2020        PMID: 33011197     DOI: 10.1016/j.brainresbull.2020.09.022

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  6 in total

1.  Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.

Authors:  Lin Wang; Bi-Qiang Zhou; Ying-Hong Li; Qian-Qian Jiang; Wei-Hong Cong; Ke-Ji Chen; Xiao-Min Wen; Zheng-Zhi Wu
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 2.  Parkin as a Molecular Bridge Linking Alzheimer's and Parkinson's Diseases?

Authors:  Frédéric Checler; Cristine Alves da Costa
Journal:  Biomolecules       Date:  2022-04-09

3.  Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease.

Authors:  Nikita Patil Samant; Girdhari Lal Gupta
Journal:  Neurotox Res       Date:  2022-01-18       Impact factor: 3.911

Review 4.  Calcium Ions Aggravate Alzheimer's Disease Through the Aberrant Activation of Neuronal Networks, Leading to Synaptic and Cognitive Deficits.

Authors:  Pei-Pei Guan; Long-Long Cao; Yi Yang; Pu Wang
Journal:  Front Mol Neurosci       Date:  2021-12-02       Impact factor: 5.639

Review 5.  ER stress and UPR in Alzheimer's disease: mechanisms, pathogenesis, treatments.

Authors:  Amir Ajoolabady; Dan Lindholm; Jun Ren; Domenico Pratico
Journal:  Cell Death Dis       Date:  2022-08-15       Impact factor: 9.685

6.  Inhibition of heat shock proteins increases autophagosome formation, and reduces the expression of APP, Tau, SOD1 G93A and TDP-43.

Authors:  Paul Dent; Laurence Booth; Jane L Roberts; Andrew Poklepovic; Derek Cridebring; Eric M Reiman
Journal:  Aging (Albany NY)       Date:  2021-07-12       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.